Oklahoma Attorney General Gentner Drummond called on the FDA to take action against counterfeit weight-loss drug ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Oklahoma Attorney General Gentner Drummond Office on Wednesday confirmed action is in order with the Food and Drug ...

The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

People are always looking for a perfect diet plan. This popularity has led to scams involving weight loss formulas claiming to offer rapid results.

Not only are these trends ineffective, but they can have serious consequences for your physical and mental health.

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Top-line data from Phase 2b IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) to be reported in Q2 ...

Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest.

Dr. Kristen Kells, founder of Colorado Springs’ largest weight loss clinic, shared insights on GLP-1 drugs and explained why the Dr. Kells Method can offer better long-term ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...